Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Epigenetic mechanisms in the development of type 2 diabetes Pinney SE; Simmons RATrends Endocrinol Metab 2010[Apr]; 21 (4): 223-9Type 2 diabetes (T2D) is a disorder of complex genetics influenced by interactions between susceptible genetic loci and environmental perturbations. Intrauterine growth retardation is one such environmental perturbation linked to the development of T2D in adulthood. An abnormal metabolic intrauterine milieu affects fetal development by permanently modifying expression of key genes regulating beta-cell development (Pdx1) and glucose transport (Glut4) in muscle. Epigenetic regulation of gene expression is one mechanism by which genetic susceptibility and environmental insults can lead to T2D. Therefore, therapeutic agents targeting epigenetic gene regulation can ultimately be used to treat T2D; however, there is much to be learned about genome-wide epigenetic programming of health and disease before these therapies can be used in patient care.|*Epigenesis, Genetic[MESH]|Chromatin Assembly and Disassembly/drug effects[MESH]|Diabetes Mellitus, Type 2/etiology/*genetics[MESH]|Fetal Growth Retardation/genetics[MESH]|Gene Expression Regulation[MESH]|Glucose Transporter Type 4/genetics[MESH]|Histones/metabolism[MESH]|Homeodomain Proteins/genetics[MESH]|Humans[MESH]|Oxidative Stress[MESH]|Trans-Activators/genetics[MESH] |